| Gene symbol | EPHA2 | Synonyms | ARCC2, CTPA, CTPP1, CTRCT6, ECK | Type of gene | protein-coding | |
| Chromosome | 1 | Map location | 1p36.13 | dbXrefs | Entrez:1969 MIM:176946 HGNC:HGNC:3386 Ensembl:ENSG00000142627 AllianceGenome:HGNC:3386 | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
| Description | EPH receptor A2 | |||||
| GTO ID | GTC1557 |
| Trial ID | NCT02575261 |
| Disease | EphA2 Positive Malignant Glioma |
| Altered gene | EPHA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EphA2 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients |
| Year | 2015 |
| Country | China |
| Company sponsor | Fuda Cancer Hospital, Guangzhou |
| Other ID(s) | CAR-T for malignant glioma |
| Cohort 1 | |||||||
|
|||||||